JP2019503979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019503979A5 JP2019503979A5 JP2017562973A JP2017562973A JP2019503979A5 JP 2019503979 A5 JP2019503979 A5 JP 2019503979A5 JP 2017562973 A JP2017562973 A JP 2017562973A JP 2017562973 A JP2017562973 A JP 2017562973A JP 2019503979 A5 JP2019503979 A5 JP 2019503979A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- conjugate
- linker
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022010563A JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562259997P | 2015-11-25 | 2015-11-25 | |
| US201562260006P | 2015-11-25 | 2015-11-25 | |
| US62/260,006 | 2015-11-25 | ||
| US62/259,997 | 2015-11-25 | ||
| PCT/IB2016/001810 WO2017089894A1 (en) | 2015-11-25 | 2016-11-23 | Conjugates comprising peptide groups and methods related thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010563A Division JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019503979A JP2019503979A (ja) | 2019-02-14 |
| JP2019503979A5 true JP2019503979A5 (enExample) | 2020-01-09 |
| JP7120765B2 JP7120765B2 (ja) | 2022-08-17 |
Family
ID=58763984
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017562973A Active JP7120765B2 (ja) | 2015-11-25 | 2016-11-23 | ペプチド基を含む複合体及びそれに関連する方法 |
| JP2022010563A Pending JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010563A Pending JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11167040B2 (enExample) |
| EP (1) | EP3380125A4 (enExample) |
| JP (2) | JP7120765B2 (enExample) |
| KR (1) | KR102847348B1 (enExample) |
| CN (1) | CN108136038A (enExample) |
| AU (1) | AU2016359234B2 (enExample) |
| CA (1) | CA3006247A1 (enExample) |
| TW (1) | TWI816638B (enExample) |
| WO (1) | WO2017089894A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9480731B2 (en) * | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
| KR101628872B1 (ko) * | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| WO2017051254A1 (en) * | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| CA3004830A1 (en) | 2015-11-11 | 2017-05-18 | Opi Vi- Ip Holdco Llc | Composition and methods for anti-tnfr2 antibodies |
| HUE067016T2 (hu) | 2015-11-25 | 2024-09-28 | Ligachem Biosciences Inc | Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások |
| CN107847605B (zh) * | 2015-11-25 | 2021-12-24 | 乐高化学生物科学股份有限公司 | 包含分支接头的抗体-药物缀合物及其相关方法 |
| JP7120765B2 (ja) * | 2015-11-25 | 2022-08-17 | レゴケム バイオサイエンシズ， インク． | ペプチド基を含む複合体及びそれに関連する方法 |
| JP7217700B2 (ja) | 2016-09-13 | 2023-02-03 | アラーガン、インコーポレイテッド | 安定化非タンパク質クロストリジウム毒素組成物 |
| JP7664680B2 (ja) | 2017-03-29 | 2025-04-18 | リガケム バイオサイエンシズ， インク． | ピロロベンゾジアゼピン二量体前駆体及びそのリガンド－リンカーコンジュゲート化合物 |
| EP3630189A4 (en) * | 2017-05-24 | 2021-06-23 | The Board of Regents of The University of Texas System | LINKER FOR ANTIBODY MEDICINAL CONJUGATES |
| CN110314238A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种肿瘤靶向的多肽药物偶联物及其制备方法和应用 |
| US11827703B2 (en) | 2018-05-09 | 2023-11-28 | Legochem Biosciences, Inc. | Compositions and methods related to anti-CD19 antibody drug conjugates |
| KR102255487B1 (ko) | 2018-07-03 | 2021-07-21 | 주식회사 엘지에너지솔루션 | 배터리 모듈, 이러한 배터리 모듈을 포함하는 배터리 팩 및 이러한 배터리 팩을 포함하는 자동차 |
| GB201817321D0 (en) | 2018-10-24 | 2018-12-05 | Nanna Therapeutics Ltd | Microbeads for tagless encoded chemical library screening |
| US20220226496A1 (en) * | 2019-05-02 | 2022-07-21 | Legochem Biosciences, Inc. | Ligand-drug conjugate including linker having tris structure |
| JP7137696B2 (ja) | 2019-05-14 | 2022-09-14 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を予防するための方法および組成物 |
| CN112094321B (zh) * | 2019-06-18 | 2022-04-22 | 首都医科大学 | His-Gly-Glu修饰的甲氨蝶呤,其合成,抗转移活性和应用 |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| CN111007244B (zh) * | 2019-11-15 | 2021-10-08 | 中国农业科学院油料作物研究所 | 二乙酸镳草镰刀菌烯醇竞争型气压免疫传感器及检测方法 |
| BR112022013008A2 (pt) * | 2019-12-31 | 2022-09-06 | Legochem Biosciences Inc | Composto derivado de pirrolobenzodiazepina, conjugado de derivado-ligante de pirrolobenzodiazepina, e, composição farmacêutica e método para prevenção ou tratamento de doença proliferativa |
| MX2022012821A (es) | 2020-04-16 | 2022-11-07 | Regeneron Pharma | Metodos de conjugacion de diels-alder. |
| GB2594753B (en) * | 2020-05-27 | 2022-05-18 | Spirea Ltd | Antibody-drug conjugates |
| KR20230092863A (ko) | 2020-06-11 | 2023-06-26 | 프로벤션 바이오, 인코포레이티드 | 제1형 당뇨병을 예방하기 위한 방법 및 조성물 |
| CN112679448B (zh) * | 2020-12-31 | 2022-08-19 | 苏州昊帆生物股份有限公司 | N-(2-氨基乙基)吗啉的制备方法 |
| EP4301782A1 (en) | 2021-03-05 | 2024-01-10 | Go Therapeutics, Inc. | Anti-glyco-cd44 antibodies and their uses |
| MX2023013851A (es) | 2021-05-24 | 2023-12-08 | Provention Bio Inc | Metodos para el tratamiento de diabetes tipo 1. |
| CN113636931B (zh) * | 2021-08-05 | 2024-02-13 | 康龙化成(宁波)科技发展有限公司 | 基因编码化合物库起始头片段化合物及其在基因编码化合物库合成上的应用 |
| JP2024531915A (ja) | 2021-08-05 | 2024-09-03 | ジーオー セラピューティクス，インコーポレイテッド | 抗グリコｍｕｃ抗体およびその使用 |
| EP4404974A1 (en) * | 2021-09-21 | 2024-07-31 | Spirea Limited | Antibody-drug conjugates |
| WO2026080692A1 (en) * | 2024-10-09 | 2026-04-16 | Sutro Biopharma, Inc. | Branched beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112739A (en) * | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
| DK0795334T3 (da) | 1996-03-12 | 2006-06-06 | Sanofi Aventis Deutschland | Nye prodrugs til behandling af tumorer og betændelsessygdomme |
| US6218519B1 (en) | 1996-04-12 | 2001-04-17 | Pro-Neuron, Inc. | Compounds and methods for the selective treatment of cancer and bacterial infections |
| US6759509B1 (en) | 1996-11-05 | 2004-07-06 | Bristol-Myers Squibb Company | Branched peptide linkers |
| EP0941120A4 (en) | 1996-11-05 | 2004-08-18 | Bristol Myers Squibb Co | BRANCHED PEPTIDLINKERS |
| JP2006510626A (ja) | 2002-12-05 | 2006-03-30 | シエーリング アクチエンゲゼルシャフト | 増殖疾患の処理における部位特異的供給のためのエポチロン類似体 |
| ES2605443T3 (es) | 2003-11-06 | 2017-03-14 | Seattle Genetics, Inc. | Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia |
| CA2578131A1 (en) | 2004-09-10 | 2006-03-23 | Wyeth | Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates |
| HUE035853T2 (en) | 2005-07-18 | 2018-05-28 | Seattle Genetics Inc | Beta-glucuronide-linker-drug conjugates |
| WO2008034120A2 (en) | 2006-09-15 | 2008-03-20 | Enzon Pharmaceuticals, Inc. | Lysine-based polymeric linkers |
| WO2008056833A1 (en) | 2006-11-10 | 2008-05-15 | Livtech Inc. | ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| CL2007003622A1 (es) | 2006-12-13 | 2009-08-07 | Medarex Inc | Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales. |
| JP5404624B2 (ja) | 2007-08-01 | 2014-02-05 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | 選択的な抗腫瘍薬として有用なピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン−グリコシドプロドラッグ |
| US9316646B2 (en) | 2009-04-23 | 2016-04-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human ROR1 antibodies |
| US9353140B2 (en) | 2009-11-25 | 2016-05-31 | Academia Sinica | BQC-G, a tumor-selective anti-cancer prodrug |
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| US9591882B2 (en) | 2010-08-05 | 2017-03-14 | Robert LaGrand Duffin | Absorbent sleeve |
| US9228023B2 (en) | 2010-10-01 | 2016-01-05 | Oxford Biotherapeutics Ltd. | Anti-ROR1 antibodies and methods of use for treatment of cancer |
| KR20120107741A (ko) | 2011-03-22 | 2012-10-04 | 한국생명공학연구원 | 패혈증 단백질 치료제의 효능 분석 및 스크리닝 방법 |
| KR101461706B1 (ko) | 2011-04-04 | 2014-11-18 | 한국생명공학연구원 | Ｄｌｋ１ 세포 외 수용성 도메인을 포함하는 액티빈 수용체 타입 2ｂ 억제제 |
| CN103502990A (zh) | 2011-04-29 | 2014-01-08 | 惠普发展公司，有限责任合伙企业 | 用于事件的内存中处理的系统和方法 |
| DK2707031T3 (da) | 2011-05-08 | 2019-10-07 | Legochem Biosciences Inc | Protein-active agent conjugates and method for preparing the same |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| EP2800586A1 (en) * | 2012-01-03 | 2014-11-12 | Invictus Oncology Pvt. Ltd. | Ligand-targeted molecules and methods thereof |
| AU2013366493B2 (en) | 2012-12-21 | 2017-08-24 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| HK1219044A1 (zh) | 2013-03-15 | 2017-03-24 | 艾伯维德国有限责任两合公司 | 抗egfr抗体药物偶联物制剂 |
| WO2014194030A2 (en) | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| WO2015052533A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| PT3057585T (pt) * | 2013-10-15 | 2020-10-21 | Seagen Inc | Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando |
| CN105813653B (zh) | 2013-12-19 | 2020-06-26 | 西雅图基因公司 | 与目标-药物偶联物并用的亚甲基氨基甲酸酯连接物 |
| EP2913064A1 (en) | 2014-02-26 | 2015-09-02 | celares GmbH | Branched drug-linker conjugates for the coupling to biological targeting molecules |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| TWI751102B (zh) | 2014-08-28 | 2022-01-01 | 美商奇諾治療有限公司 | 對ｃｄ１９具專一性之抗體及嵌合抗原受體 |
| HRP20241124T1 (hr) | 2014-09-11 | 2024-11-22 | Seagen Inc. | Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin |
| JP2018502839A (ja) | 2014-12-09 | 2018-02-01 | アッヴィ・インコーポレイテッド | Ｂｃｌ−ｘＬ阻害性化合物およびこれを含む抗体薬物コンジュゲート |
| KR20160080832A (ko) | 2014-12-29 | 2016-07-08 | 주식회사 레고켐 바이오사이언스 | 리피바디 유도체-약물 복합체, 그 제조방법 및 용도 |
| US20160208018A1 (en) | 2015-01-16 | 2016-07-21 | Juno Therapeutics, Inc. | Antibodies and chimeric antigen receptors specific for ror1 |
| CN114716506A (zh) | 2015-01-30 | 2022-07-08 | 苏特罗生物制药公司 | 用于偶联和治疗的哈米特林（hemiasterlin）衍生物 |
| WO2017051254A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| SG11201803054UA (en) | 2015-10-13 | 2018-05-30 | Eureka Therapeutics Inc | Antibody agents specific for human cd19 and uses thereof |
| CN107847605B (zh) | 2015-11-25 | 2021-12-24 | 乐高化学生物科学股份有限公司 | 包含分支接头的抗体-药物缀合物及其相关方法 |
| HUE067016T2 (hu) | 2015-11-25 | 2024-09-28 | Ligachem Biosciences Inc | Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások |
| JP7120765B2 (ja) * | 2015-11-25 | 2022-08-17 | レゴケム バイオサイエンシズ， インク． | ペプチド基を含む複合体及びそれに関連する方法 |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| CA3040812A1 (en) | 2016-11-04 | 2018-05-11 | Novimmune Sa | Anti-cd19 antibodies and methods of use thereof |
| JP7664680B2 (ja) | 2017-03-29 | 2025-04-18 | リガケム バイオサイエンシズ， インク． | ピロロベンゾジアゼピン二量体前駆体及びそのリガンド－リンカーコンジュゲート化合物 |
| TWI804499B (zh) | 2017-06-23 | 2023-06-11 | 美商維洛斯生物公司 | Ror1抗體免疫接合物 |
| KR20190018400A (ko) | 2017-08-14 | 2019-02-22 | 주식회사 레고켐 바이오사이언스 | EGFRvIII에 대한 항체를 포함하는 항체 약물 접합체 |
| WO2019050362A2 (ko) | 2017-09-08 | 2019-03-14 | 주식회사 와이바이오로직스 | 인간 dlk1에 대한 항체 및 이의 용도 |
| US11827703B2 (en) | 2018-05-09 | 2023-11-28 | Legochem Biosciences, Inc. | Compositions and methods related to anti-CD19 antibody drug conjugates |
| WO2019225777A1 (ko) | 2018-05-23 | 2019-11-28 | 에이비엘바이오 주식회사 | 항-ror1 항체 및 그 용도 |
| JP7664045B2 (ja) | 2019-03-06 | 2025-04-17 | リガケム バイオサイエンシズ， インク． | ヒトｄｌｋ１に対する抗体を含む抗体薬物コンジュゲート及びその使用 |
-
2016
- 2016-11-23 JP JP2017562973A patent/JP7120765B2/ja active Active
- 2016-11-23 AU AU2016359234A patent/AU2016359234B2/en active Active
- 2016-11-23 CA CA3006247A patent/CA3006247A1/en active Pending
- 2016-11-23 US US15/779,450 patent/US11167040B2/en active Active
- 2016-11-23 EP EP16868095.7A patent/EP3380125A4/en active Pending
- 2016-11-23 WO PCT/IB2016/001810 patent/WO2017089894A1/en not_active Ceased
- 2016-11-23 CN CN201680030739.4A patent/CN108136038A/zh active Pending
- 2016-11-23 KR KR1020187018067A patent/KR102847348B1/ko active Active
- 2016-11-25 TW TW105138779A patent/TWI816638B/zh active
-
2022
- 2022-01-27 JP JP2022010563A patent/JP2022068172A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019503981A5 (enExample) | ||
| JP2019503980A5 (enExample) | ||
| HRP20240795T1 (hr) | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima | |
| KR101921068B1 (ko) | 단백질-활성제 접합체 및 이의 제조 방법 | |
| JP7598403B2 (ja) | 抗体薬物複合体及びその応用 | |
| US10036010B2 (en) | Recognition tags for TGase-mediated conjugation | |
| KR102847350B1 (ko) | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 | |
| KR102847348B1 (ko) | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 | |
| JP2021113210A (ja) | 抱合方法 | |
| JP2021523232A5 (enExample) | ||
| JP7256751B2 (ja) | β－ガラクトシドが導入された自己犠牲リンカーを含む化合物 | |
| JPS61227532A (ja) | 抗体ハイブリツド分子およびその製造方法 | |
| NZ200302A (en) | Antimelanoma drugs containing antibodies | |
| JP2022522547A5 (enExample) | ||
| JP2024160336A (ja) | トリス構造を有するリンカーを含むリガンド―薬物複合体 | |
| US20240261425A1 (en) | Conjugate and the preparing method and use thereof | |
| WO2024078612A1 (en) | Linker-payload compound, conjugates and applications thereof | |
| KR102501394B1 (ko) | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 | |
| KR20250163875A (ko) | 핵 위치화 폴리펩타이드 및 컨주게이트 및 이의 용도 | |
| RU2787617C2 (ru) | Конъюгаты антитело-лекарственное средство и их применение | |
| RU2025127084A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитела против l1cam человека, и его применение | |
| RU2020140202A (ru) | Композиции и способы, относящиеся к конъюгатам лекарственных средств с антителами против cd19 | |
| HK40017656A (en) | Protein-active agent conjugates and method for preparing the same |